4.8 Article

Mineralocorticoid Receptor Phosphorylation Regulates Ligand Binding and Renal Response to Volume Depletion and Hyperkalemia

Journal

CELL METABOLISM
Volume 18, Issue 5, Pages 660-671

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2013.10.005

Keywords

-

Funding

  1. National Institutes of Health [P01-DK017433, P30-DK079310, UL1-RR024139, K01-DK089006]
  2. Leducq Transatlantic Network on Hypertension
  3. Uehara Memorial Foundation

Ask authors/readers for more resources

Nuclear receptors are transcription factors that regulate diverse cellular processes. In canonical activation, ligand availability is sufficient to produce receptor binding, entraining downstream signaling. The mineralocorticoid receptor (MR) is normally activated by aldosterone, which is produced in both volume depletion and hyperkalemia, states that require different homeostatic responses. We report phosphorylation at S843 in the MR ligand-binding domain that prevents ligand binding and activation. In kidney, MRS843-P is found exclusively in intercalated cells of the distal nephron. In volume depletion, angiotensin II and WNK4 signaling decrease MRS843-P levels, whereas hyperkalemia increases MRS843-P. Dephosphorylation of MRS843-P results in aldosterone-dependent increases of the intercalated cell apical proton pump and Cl-/HCO3- exchangers, increasing Cl- reabsorption and promoting increased plasma volume while inhibiting K+ secretion. These findings reveal a mechanism regulating nuclear hormone receptor activity and implicate selective MR activation in intercalated cells in the distinct adaptive responses to volume depletion and hyperkalemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available